Search Results

There are 58199 results for: content related to: Lack of association between genetic polymorphisms of CYP 3A4 , CYP 2C9 and CYP 2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population

  1. CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 11, November 2014, Pages: 870–878, Rasmus Steen Pedersen, Flemming Nielsen, Tore Bjerregaard Stage, Pernille Just Vinholt, Alaa Bilal el Achwah, Per Damkier and Kim Brosen

    Version of Record online : 26 NOV 2014, DOI: 10.1111/1440-1681.12297

  2. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients

    Clinical Transplantation

    Volume 30, Issue 9, September 2016, Pages: 1074–1081, Kimberly M. Deininger, Anh Vu, Robert L. Page II, Amrut V. Ambardekar, JoAnn Lindenfeld and Christina L. Aquilante

    Version of Record online : 11 JUL 2016, DOI: 10.1111/ctr.12790

  3. You have free access to this content
    Clinical significance of CYP2C9-status guided valproic acid therapy in children


    Volume 56, Issue 6, June 2015, Pages: 849–855, Tamás Bűdi, Katalin Tóth, Andrea Nagy, Zsuzsa Szever, Ádám Kiss, Manna Temesvári, Edit Háfra, Miklós Garami, Adrienn Tapodi and Katalin Monostory

    Version of Record online : 13 MAY 2015, DOI: 10.1111/epi.13011

  4. Cytochrome P450 Enzymes

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Eugene G. Hrycay and Stelvio M. Bandiera

    Published Online : 15 MAR 2010, DOI: 10.1002/9780470571224.pse048

  5. Non-antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 1, January 2015, Pages: 22–26, Yin-Zhuang Zhang, Bi-Lian Chen, Wei Zhang and Xin Cao

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1440-1681.12325

  6. You have full text access to this Open Access content
    Analysis of CYP2C9*2,CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 12, December 2012, Pages: 2919–2924, Anca D. Buzoianu, Adrian P. Trifa, Dafin F. Mureşanu and Sorin Crişan

    Version of Record online : 13 DEC 2012, DOI: 10.1111/j.1582-4934.2012.01606.x

  7. In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 3, June 2015, Pages: 320–327, Y. Ji, S. Chen, L. Zhao, P. Pan, L. Wang, J. Cai, D. Dai, G. Hu, J. P. Cai and H. Huang

    Version of Record online : 17 APR 2015, DOI: 10.1111/jcpt.12267

  8. You have full text access to this OnlineOpen article
    Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Sarada D. Ramachandran, Aurélie Vivarès, Sylvie Klieber, Nicola J. Hewitt, Bernhard Muenst, Stefan Heinz, Heike Walles and Joris Braspenning

    Version of Record online : 10 AUG 2015, DOI: 10.1002/prp2.161

  9. You have free access to this content
    Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19

    British Journal of Clinical Pharmacology

    Volume 77, Issue 3, March 2014, Pages: 554–570, Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan and Jashvant D. Unadkat

    Version of Record online : 21 FEB 2014, DOI: 10.1111/bcp.12207

  10. Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 5, October 2014, Pages: 551–582, Zhi-Xin Wang, Jiazhi Sun, Caitlin E. Howell, Qing-Yu Zhou, Zhi-Xu He, Tianxin Yang, Helen Chew, Wei Duan, Zhi-Wei Zhou, Jagat R. Kanwar and Shu-Feng Zhou

    Version of Record online : 21 MAR 2014, DOI: 10.1111/fcp.12069

  11. Cytochrome P450 Polymorphisms

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Ulrich M. Zanger

    Published Online : 31 JAN 2012, DOI: 10.1002/9780470921920.edm009

  12. You have free access to this content
    In Vitro Assessment of 36 CYP2C9 Allelic Isoforms Found in the Chinese Population on the Metabolism of Glimepiride

    Basic & Clinical Pharmacology & Toxicology

    Volume 114, Issue 4, April 2014, Pages: 305–310, Da-Peng Dai, Shuang-Hu Wang, Pei-Wu Geng, Guo-Xin Hu and Jian-Ping Cai

    Version of Record online : 8 NOV 2013, DOI: 10.1111/bcpt.12159

  13. Increased CYP24A1 expression is associated with BRAFV600E mutation and advanced stages in papillary thyroid carcinoma

    Clinical Endocrinology

    Volume 81, Issue 1, July 2014, Pages: 109–116, Minjing Zou, Faisal S. BinHumaid, Ali S. Alzahrani, Essa Y. Baitei, Futwan A. Al-Mohanna, Brian F. Meyer and Yufei Shi

    Version of Record online : 21 JAN 2014, DOI: 10.1111/cen.12396

  14. Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 10, October 2013, Pages: 683–688, Rasmus S. Pedersen, Lene Noehr-Jensen and Kim Brosen

    Version of Record online : 23 SEP 2013, DOI: 10.1111/1440-1681.12153

  15. Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 7, July 2015, Pages: 972–979, Hamsa T. Tayeb, Dana H. Bakheet, Khaled Zaza, Salma M. Wakil and Nduna Dzimiri

    Version of Record online : 14 FEB 2015, DOI: 10.1111/jphp.12391

  16. Influence of CYP2C8*2 on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 9, September 2013, Pages: 1000–1007, Christina L. Aquilante, Michael F. Wempe, Samantha H. Spencer, Lisa A. Kosmiski, Julie A. Predhomme and Maha S. Sidhom

    Version of Record online : 26 MAY 2013, DOI: 10.1002/phar.1292

  17. You have free access to this content
    Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors

    Basic & Clinical Pharmacology & Toxicology

    Volume 117, Issue 4, October 2015, Pages: 261–266, Stina Betts, Linda Björkhem-Bergman, Anders Rane and Lena Ekström

    Version of Record online : 9 MAR 2015, DOI: 10.1111/bcpt.12392

  18. You have free access to this content
    Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study

    British Journal of Haematology

    Volume 167, Issue 4, November 2014, Pages: 547–553, Sophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, Raute Sunder-Plassmann, Georgiana-Aura Giurgea, Alexandra Hammer, Christian Margeta, Martin Brunner, Renate Koppensteiner and Christine Mannhalter

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bjh.13082

  19. You have free access to this content
    The CYP2C19*17 variant is not independently associated with clopidogrel response

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 9, September 2013, Pages: 1640–1646, J. P. Lewis, S. H. Stephens, R. B. Horenstein, J. R. O'Connell, K. Ryan, C. J. Peer, W. D. Figg, S. D. Spencer, M. A. Pacanowski, B. D. Mitchell and A. R. Shuldiner

    Version of Record online : 12 SEP 2013, DOI: 10.1111/jth.12342

  20. Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 4, April 2012, Pages: 340–353, Mark Walzer, Ihor Bekersky, Robert A. Blum and Dwain Tolbert

    Version of Record online : 15 MAR 2012, DOI: 10.1002/j.1875-9114.2012.01028.x